MANAge-DM: Nurse Case Management for Diabetes in Formerly Incarcerated Black Men
This study, called MANAGe-DM, is testing a new type of nurse support for formerly incarcerated Black men with type 2 diabetes (a condition where your body doesn't use sugar properly, leading to high blood sugar). All participants will receive monthly diabetes education mailings. Some will also get extra support from a nurse case manager through two phone calls each month. The study aims to see if this extra support improves blood sugar control (measured by Hemoglobin A1C, a test that shows your average blood sugar over 2-3 months) and other health outcomes after 6 months. You might be able to join if you are a Black or African American man, at least 18 years old, have been incarcerated, have type 2 diabetes with an HbA1c of 8% or higher, and can speak English. The study is currently unclear on its recruitment status and plans to enroll 100 participants.
- Study design
- This is a randomized control trial involving 100 participants. Participants will be assigned by chance to either receive monthly educational mailings or the mailings plus nurse case management.
- What's involved
- Participants will receive monthly diabetes education mailings. If assigned to the nurse case management group, you will also have two phone calls with a nurse each month for the study period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your Hemoglobin A1C will be measured at 6 months after you are assigned to a group.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Laura Hawks, MD · PRINCIPAL_INVESTIGATOR · Medical College of Wisconsin
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Hemoglobin A1C6 months post-randomization
Venous draw will be use to obtain HbA1C